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Abstract 
The  health  background  management  and
outcomes of 5 pregnancies in 4 women affect-
ed by Cooley Disease, from Paediatric Institute
of Catania University, are described, consider-
ing the preconceptual guidances and cares for
such  patients.  These  patients  were  selected
among  a  group  of  100  thalassemic  women
divided  into  three  subgroups,  according  to
their first and successive menstruation char-
acteristics: i) patients with primitive amenor-
rhoea,  ii)  patients  with  secondary  amenor-
rhoea and iii) patients with normal menstrua-
tion. Only one woman, affected by primitive
amenorrhoea, needed the induction of ovula-
tion.  A  precise  and  detailed  pre-pregnancy
assessment was effected before each concep-
tion.  This  was  constituted  by  a  series  of
essays,  including  checks  for  diabetes  and
hypothyroidism, for B and C hepatitis and for
blood group antibodies. Moreover were evalu-
ated: cardiac function, rubella immunity and
transaminases. Other pregnancy monitoring,
and  cares  during  labour  and  delivery  were
effected according to usual obstetrics practice.
All  the  women  were  in  labour  when  she
were 38 week pregnant, and the outcome were
five  healthy  babies  born  at  term,  weighting
between 2600 and 3200gs. The only complica-
tion was the Caesarean section. The improve-
ments of current treatments, especially in the
management of iron deposits, the prolongation
of  survival  rate,  will  result  in  a  continuous
increase  of  pregnancies  in  thalassemic
women. Pregnancy is now a real possibility for
women affected by such disease. We are fur-
thermore studying the possibility to collect the
fetus' umbilical cord blood, after the delivery,
to  attempt  eterologus  transplantation  to  his
mother trying to get a complete marrow recon-
stitution. 
Introduction
Beta Thalassemia major, also called Cooley
disease,  is  a  severe  transfusion-dependent
anaemia which often causes infertility due to
the iron deposits in endocrine organs follow-
ing multiple blood transfusions, needed to care
this illness. Gonadal function is impaired in
the  majority  of  the  patients  affected  by  the
homozygous kind of this disease and, especial-
ly  in  females,  this  is  expressed  either  by  a
delay in the onset of puberty and menstruation
or by secondary amenorrhoea.1 The common-
est abnormality was hypogonadotropic hypogo-
nadism, but the relatively high prevalence of
other endocrine impairments, causing multi-
ple endocrinopathies, is also well recognised.
These  kind  of  endocrine  complications  are
directly related to the serum ferritin level.2The
aetiology of the above mentioned reproductive
disorders is linked to an anatomical and func-
tional disarray of the components of the cen-
tral nervous system-gonadal axis and the func-
tionality is often impaired at all three levels,
i.e. gonads, anterior pituitary and hypothala-
mus.3-5 Up to the end of 1980 there were only
some  reports  of  pregnancy  in  patients  with
beta Thalassemia major and, only few of them
were  carried  out  successfully.6-8 Nowadays,
thanks to improved paediatric and haemato-
logical cares, patients affected by Cooley dis-
ease may live on to be forty or fifty, and can
enjoy a quite regular standard of life. So that,
maintaining  a  strict  therapeutic  regimen,
women regularly transfused and well chelated
can  attempt  to  become  pregnant.9-12 In  this
report we describe the evolution and the suc-
cessful outcome of five at term pregnancies
carried out by four women affected by transfu-
sion dependent beta Thalassemia. In review-
ing the cares and the complications during and
after their pregnancies, we discuss the issue
concerning  the  appropriate  preconception
counselling of such patients. 
Materials and Methods 
For several years we have been following one
hundred  women  affected  by  transfusion
dependent beta Thalassemia major, diagnosed
when they were between 6 and 8 months old,
from the endocrine and reproductive point of
view. All of them, who attended the Paediatric
Institute  of  Catania  University,  were  aged
between 23 to 29 and received a blood transfu-
sion every 15-20 days, in order to maintain the
haemoglobin concentration above 10 g/dL; and
were in strict desferrioxamine chelating thera-
py,  to  avoid  excessive  iron  overloads.  The
patients have been divided into three groups
according to their first and successive menstru-
ation characteristics: i) patients with primitive
amenorrhoea,  ii)  patients  with  secondary
amenorrhoea  and  iii)  patients  with  normal
menstruation.  In  detail  twenty  out  of  these
women got married: four were affected by prim-
itive amenorrhoea; six were affected by second-
ary one and the remaining ten women had nor-
mal  menstruation.  Finally  five  pregnancies
occurred  among  these  twenty  women:  two
among  the  patients  affected  respectively  by
primitive  and  secondary  amenorrhoea,  and
three were carried out by women with sponta-
neous menstruation. Considering as to the last
three pregnancies, it is remarkable that to this
group belonged a woman that had two success-
ful childbirths; so the total number of women
we followed was four (Figures 1, 2; Table 1).
Average values of ferritin fluctuated between
500 and 1000 ng/mL, and transaminases were
between 25 and 100 U/L. All of them were vacci-
nated against Hepatitis B Virus (HBV), and two
were  splenectomized,  particularly  the  woman
affected by primitive amenorrhoea and one of
those  with  normal  periods.  Only  the  woman
affected by primitive amenorrhoea needed the
induction of ovulation to stimulate her pregnan-
cy. Evaluation of eligibility depends upon the
results of a series of examinations regarding
hearth, kidneys, thyroid, pancreas and periph-
eral  arteries.  Haemo  siderotic  parenchimal
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deterioration, particularly of the myocardium,
makes these patients potentially fragile, while
the induction of ovulation may be a hard stress
test even for a healthy woman. All the other
women  had  spontaneous  and  physiological
pregnancies. It is finally important to underline
that all the partners of these women were neg-
ative as regards the thalassemic trait. According
to  the  guidelines  previously  established  by
Susan M. Tuck,13 a precise and detailed pre-
pregnancy assessment was effected before each
conception. This was constituted by a series of
clinical and laboratory essays, including checks
for diabetes and hypothyroidism, for B and C
hepatitis  and  for  blood  group  antibodies.
Cardiac function was assessed symptomatically
and by echocardiography and exercise electro-
cardiography.  Rubella  immunity  was  checked
and immunisation was given when the woman
was found to be susceptible. During pregnancy
the monitoring of all these factors continued,
including frequent checks of aminotransferase
(AST and ALT transaminases). The frequency of
blood transfusion had to be increased, the aim
being to maintain the pre-transfusion haemo-
globin concentration. Desferrioxamine therapy
was stopped as soon as pregnancy was diag-
nosed, because using this drug during gestation
could notoriously induce teratogenic effects on
the foetus, but the average values of ferritin
were just a little higher than the normal range
observed. Probably the foetus, due to a particu-
lar chelating activity, maintains it during gesta-
tion. This therapy was quickly resumed after
delivery.14 Other pregnancy monitoring, such as
for blood pressure, for proteinuria and for fetal
growth, and cares during labour and delivery
were effected according to usual obstetrics prac-
tice and criteria. 
Results
Only one out of the five pregnancies we have
followed  needed  the  induction  of  ovulation.
Moreover  a  same  woman  carried  out  two  of
them. All the women were in labour when she
were 38 week pregnant, and the outcome were
five  healthy  babies  born  at  term  weighting
between 2600 and 3200gs. The caesarean deliv-
ery was preferred because of the frequent infer-
tility/sterility that occurs in the natural history
of such kind of patients. All of these women
were neither HIV positive nor suffered from dia-
betes, however they were controlled with a diet.
All of them reported transaminases raising, but
only in one case it was necessary to practice a
therapy  based  on  silimarina.  Moreover  all  of
them had transfusion-transmitted C hepatitis
prior to pregnancy, but only the one affected by
secondary  amenorrhoea  received  curses  of
interferon two years before embarking on preg-
nancy, because she showed to be positive for
HCV-RNA. Four out of the babies born were HCV
negative, while only one was HCV positive but
HCV-RNA negative, so that it was not necessary
to prescribe a therapy.
Finally, there were neither cardiac dysfunc-
tions nor kidney diseases reported, or other
important affections.
Discussion 
We believe that several ethical and theoretical
questions should be evaluated before the obser-
vation of technical problems. We should never
forget that Beta thalassemic are fragile patients
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Table 1. Table expressing the number of married women, the pregnancies, the medium
age and the amount of each group, according to a subdivision in three categories -
Normal menstruation, Secondary Amenorrhoea and Primitive Amenorrhoea – in refer-
ence to the total amount of the 100 patients we studied.
Menstruation   Normal Secondary Primary
characteristics menstruation amenorrhea amenorrhea
Married women 10 64
Number of pregnancy 3 (30%) 1 (16.6%) 1 (25%)
Spontaneous pregnancy 3 (100%) 1 (100%) -
Induced pregnancy -- 1 (100%)
Medium Age 21.4±2.2 23.7±1.9 25.1±3.4
Figure  1.  Flow  chart  representing  the  distribution  of  100  women  affected  by  Beta
Thalassemia major subdivided in three categories, according to their menstruation char-
acteristics; considering if they are married or singles, and the number of pregnancies car-
ried out by each group.
Figure 2. Graphic expressing the percentage of married women in reference to each group
in which we subdivided them. [page 12] [Hematology Reports 2011; 3:e4]
who are knowingly exposed to a large quantity of
risks. It is the doctor’s responsibility to decide
which  patient  can  afford  ovulation  induction,
when  needed,  pregnancy  and  labour,  with  an
acceptable degree of risk, and which are the lim-
its  of  this  risk.  As  regards  the  possibility  to
induce a pregnancy in women affected by such
disease, this activity was judged to be perfectly
moral from the chatolic point of view by the
Center for Bioethics of the Chatolic University of
the Sacred Heart, Rome, as it was explained in
previous studies regarding this matter.15
Finally,  the  improvements  of  current  con-
ventional treatments, especially in the man-
agement of iron deposits, the prolongation of
survival  rate,  and  the  new  approaches  to
assisted conception, when needed, will result
in  a  continuous  increase  of  pregnancies  in
women  affected  by  beta  Thalassemia.
According  to  the  several  advances  in  treat-
ment, occurred from the 1980s, and to pericon-
ceptional counselling - concerning the contin-
uation of pregnancy only in women in good
general conditions - intrauterine growth retar-
dation,  foetal  loss  and  preterm  labour  are
remarkably reducing. 
Concluding we can state that pregnancy is
now a real possibility for women affected by
Cooley  disease  that  are  regularly  transfused
and well chelated. Pregnancy does not have a
deleterious effect on the course of their dis-
ease, and on the general well being of the foe-
tus. It seems, in fact, that the evaluation of car-
diac function, in combination with a low iron
load  and  satisfactory  endocrine  and  hepatic
controls can ensure a pregnancy outcome with
minimal adverse effects, and not severe obstet-
ric complications except for the high incidence
of caesarean sections.16
Then it is possible to think about a normal
pregnancy without fetal loss, foetus' intrauter-
ine growth retardation and preterm labour, like
it is commonly believed. We are furthermore
studying the possibility to collect a good quan-
tity of umbilical cord blood of the foetus, after
the delivery and before placental detachment,
to  attempt  eterologus  transplantation  to  the
mother (Figure 3).17 This is to be hoped, espe-
cially if the mother is totally HLA-matched or
also partially matched with her son, because
umbilical cord blood has shown to possess a
significant quantity of CD34+stem cells. These
particular  haematological  stem  cells  have  a
great capacity to repopulate the bone marrow
and now are being used to intent an alterna-
tive approach to several both malignant and
not haematological disease. So, by using this
procedure, after several laboratory passages of
CD34+ recovering,  metabolism  monitoring,
enrichment and clonogenic culture, we aim at
trying to get a complete marrow reconstitution
of the thalassemic mother, thanks to the help
offered by her donor son. 
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Figure 3. Photograph showing the collec-
tion of umbilical cord blood, containing a
large quantity of CD34+ stem cells, during
a  caesarean  section,  in  a  thalassemic
woman. 